BioSpace News Archive

The growing prevalence of diabetes is one of the significant factors influencing market growth.

An immunosuppressant stops the immune system from damaging healthy tissues and cells by slowing down or ceasing the response of the immune system that mistakenly attacks the healthy tissues and cells.

Self-monitoring blood glucose is a modern procedure for diabetes management to check the glucose level instantly and measure the precise capillaries glucose concentration.

Fluidigm Corporation, an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced that it will report second quarter 2021 financial results on Thursday, August 5, 2021, after the close of the market.

Exelixis, Inc. announced that Peter Lamb, Ph.D., the company’s Executive Vice President, Scientific Strategy and Chief Scientific Officer, will present at the virtual William Blair Biotech Focus Conference 2021 on Thursday, July 15th at 2:00 p.m. EDT / 1:00 p.m. CDT / 11:00 a.m. PDT.

AVEO Oncology announced that it will host a key opinion leader webinar focusing on FOTIVDA®, AVEO’s oral, once-daily, differentiated vascular endothelial growth factor receptor tyrosine kinase inhibitor for the treatment of adult patients with relapsed or refractory renal cell carcinoma following two or more prior systemic therapies, on Friday, July 16, 2021 at 12:00 p.m. Eastern Time.

Researchers at the University of Chicago and the U.S. Department of Energy’s Argonne National Laboratory have imaged a whole mouse brain across five orders of magnitude of resolution, which researchers say will better connect existing imaging approaches and uncover new details about the structure of the brain.

Growing requirement in surgeries along with increasing application of lidocaine in dental procedures are the major factor influencing market growth.

Therma Bright Inc. (TSXV: THRM) (“Therma” or the “Company”), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, is pleased to announce the completion and validation that its AcuVid™ COVID-19 Rapid Antigen Saliva Test successfully detected the highly contagious, fast moving COVID-19 Delta B.1.617.2 variant.

Zymeworks Inc. today announced that the Company will present at the upcoming Ladenburg Thalmann Healthcare Conference on July 14, 2021 at 4:00 p.m. ET.